64B16-28.301: Destruction of Controlled Substances - Class I Institutional Pharmacies - Nursing Homes
PURPOSE AND EFFECT: The Board proposes the rule amendment to clarify the requirements for witnessing destruction of controlled substances.
SUMMARY: The requirements for witnessing destruction of controlled substances will be clarified.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared. The Board determined the proposed rule will not have an impact on small business.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 465.005, 465.022 FS.
LAW IMPLEMENTED: 456.022, 465.019 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253
THE FULL TEXT OF THE PROPOSED RULE IS:
64B16-28.301 Destruction of Controlled Substances – Class I Institutional Pharmacies – Nursing Homes.
(1) No change.
(2) A document must be completed showing the name and quantity of the drug, strength and dosage form, patient’s name, prescription number and name of the institution nursing home. This documentation, at the time of destruction, shall be witnessed and signed by the consultant pharmacist, director of nursing, and the nursing home administrator or his designee, which may include a licensed physician, pharmacist, mid-level practitioner, or nurse. excluding the above.
Rulemaking Specific Authority 465.005, 465.022 FS. Law Implemented 465.022, 465.019 FS. History–New 4-21-87, Formerly 21S-19.001, Amended 7-31-91, Formerly 21S-28.301, 61F10-28.301, Amended 1-30-96, Formerly 59X-28.301, Amended________.